BR9813099A - Seleção positiva-negativa na recombinação homóloga - Google Patents

Seleção positiva-negativa na recombinação homóloga

Info

Publication number
BR9813099A
BR9813099A BR9813099-4A BR9813099A BR9813099A BR 9813099 A BR9813099 A BR 9813099A BR 9813099 A BR9813099 A BR 9813099A BR 9813099 A BR9813099 A BR 9813099A
Authority
BR
Brazil
Prior art keywords
homologous recombination
positive
negative selection
recombination
genome
Prior art date
Application number
BR9813099-4A
Other languages
English (en)
Other versions
BR9813099B1 (pt
Inventor
Johannes Auer
Raimund Sprenger
Konrad Honold
Original Assignee
Roche Diagnostics Gmgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9813099(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmgh filed Critical Roche Diagnostics Gmgh
Publication of BR9813099A publication Critical patent/BR9813099A/pt
Publication of BR9813099B1 publication Critical patent/BR9813099B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"SELEçãO POSITIVA-NEGATIVA NA RECOMBINAçãO HOMóLOGA''<D>. A invenção refere-se a um processo para a introdução de um DNA estranho no genoma de uma célula visada mediante recombinação homóloga, bem como para a recombinação homóloga de construções de DNA adequadas.
BRPI9813099-4A 1997-10-20 1998-10-20 processo para a introduÇço de dna exàgeno em uma cÉlula hospedeira mediante recombinaÇço homàloga, vetor recombinante, bem como emprego do referido vetor e de receptores superficiais em posiÇço de membrana. BR9813099B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97118175 1997-10-20
EP97118175.5 1997-10-20
PCT/EP1998/006616 WO1999020780A1 (de) 1997-10-20 1998-10-20 Positiv-negativ-selektion bei der homologen rekombination

Publications (2)

Publication Number Publication Date
BR9813099A true BR9813099A (pt) 2000-08-22
BR9813099B1 BR9813099B1 (pt) 2010-02-09

Family

ID=8227499

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9813099-4A BR9813099B1 (pt) 1997-10-20 1998-10-20 processo para a introduÇço de dna exàgeno em uma cÉlula hospedeira mediante recombinaÇço homàloga, vetor recombinante, bem como emprego do referido vetor e de receptores superficiais em posiÇço de membrana.

Country Status (17)

Country Link
US (1) US6284541B1 (pt)
EP (1) EP1025253B2 (pt)
JP (1) JP4417549B2 (pt)
KR (1) KR100566702B1 (pt)
CN (1) CN1146666C (pt)
AR (1) AR017368A1 (pt)
AT (1) ATE260982T1 (pt)
AU (1) AU730466B2 (pt)
BR (1) BR9813099B1 (pt)
CA (1) CA2306229C (pt)
DE (1) DE59810925D1 (pt)
DK (1) DK1025253T4 (pt)
ES (1) ES2213925T5 (pt)
PT (1) PT1025253E (pt)
TR (1) TR200001046T2 (pt)
WO (1) WO1999020780A1 (pt)
ZA (1) ZA989497B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220221B2 (en) * 2000-05-03 2007-05-22 Nautilus, Inc. Exercise device with body extension mechanism
AU2001289104A1 (en) 2000-09-15 2002-03-26 Deltagen, Inc. Methods of producing cells and animals comprising targeted gene modifications
WO2002055687A2 (en) * 2000-12-13 2002-07-18 Deltagen Inc Transgenic mice containing target gene disruptions
WO2003027261A2 (en) * 2001-09-27 2003-04-03 Functional Genetics, Inc. Methods and compositions for gene targeting by homologous recombination
ES2350248T3 (es) 2001-10-01 2011-01-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Procedimiento de producción de bibliotecas de proteínas y de selección de proteínas a partir de las mismas.
AU2002351233A1 (en) * 2001-12-04 2003-06-17 Genome Biosciences, Llc Gene targeting methods and vectors
EP1501927A2 (en) * 2002-05-02 2005-02-02 University Of North Carolina At Chapel Hill In vitro mutagenesis, phenotyping, and gene mapping
FR2860517B1 (fr) * 2003-10-03 2006-02-10 Evologic Sa Procedes et outils pour la modification chromosomique de bacteries
CN102925479A (zh) 2005-03-08 2013-02-13 巴斯福植物科学有限公司 增强表达的内含子序列
CA2661848C (en) 2006-09-01 2015-02-03 Therapeutic Human Polyclonals, Inc. Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
JP2010525812A (ja) 2007-05-02 2010-07-29 メリアル リミテッド 発現及び安定性が改善されたｄｎａプラスミド
US20110136236A1 (en) * 2008-04-21 2011-06-09 Unitargeting Research As Genetically modified eukaryotic cells
CN102618453A (zh) * 2011-10-31 2012-08-01 四川农业大学 猪传染性胸膜肺炎放线杆菌Apx I C基因缺失突变株、构建方法、疫苗及应用
US9303272B2 (en) 2011-12-13 2016-04-05 Public University Corporation Yokohama City University Gene targeting vector, and method for using same
DE102014116334A1 (de) * 2014-11-10 2016-05-12 Eberhard Karls Universität Tübingen Medizinische Fakultät Herstellung von rekombinanten Expressionsvektoren

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01203975A (ja) * 1988-02-09 1989-08-16 Konica Corp 流体試料中の特定成分の測定方法
DE3907679A1 (de) * 1989-03-09 1990-09-13 Max Planck Gesellschaft Verfahren zur gezielten veraenderung eines gens
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
DE69032809T2 (de) † 1989-11-06 1999-07-08 Cell Genesys, Inc., Foster City, Calif. Herstellung von Proteinen mittels homologer Rekombination
CA2040099A1 (en) 1990-05-01 1991-11-02 Mariano Barbacid Tyrosine kinase negative trkb
AU9164991A (en) * 1990-11-30 1992-06-25 Abbott Laboratories Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor
PT101031B (pt) † 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
EP1553168A3 (en) * 1993-06-04 2011-04-06 The United States of America as represented by The Secretary of The Navy Methods for selectively stimulating proliferation of T cells
IT1261847B (it) 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6017754A (en) * 1995-08-24 2000-01-25 Invitrogen Corporation System for isolating and identifying eukaryotic cells transfected with genes and vectors, host cells and methods thereof

Also Published As

Publication number Publication date
ATE260982T1 (de) 2004-03-15
EP1025253A1 (en) 2000-08-09
US6284541B1 (en) 2001-09-04
ZA989497B (en) 2000-04-19
TR200001046T2 (tr) 2001-07-23
EP1025253B1 (de) 2004-03-03
CA2306229A1 (en) 1999-04-29
JP4417549B2 (ja) 2010-02-17
WO1999020780A1 (de) 1999-04-29
DK1025253T3 (da) 2004-07-12
CN1276836A (zh) 2000-12-13
KR100566702B1 (ko) 2006-04-03
CN1146666C (zh) 2004-04-21
AU730466B2 (en) 2001-03-08
CA2306229C (en) 2011-03-22
ES2213925T5 (es) 2009-11-11
DE59810925D1 (de) 2004-04-08
AU1229399A (en) 1999-05-10
AR017368A1 (es) 2001-09-05
JP2001523442A (ja) 2001-11-27
EP1025253B2 (de) 2009-07-29
BR9813099B1 (pt) 2010-02-09
ES2213925T3 (es) 2004-09-01
KR20010031277A (ko) 2001-04-16
DK1025253T4 (da) 2009-08-31
PT1025253E (pt) 2004-07-30

Similar Documents

Publication Publication Date Title
BR9813099A (pt) Seleção positiva-negativa na recombinação homóloga
BR9815855A (pt) Genes e métodos para controle de nematóides em plantas
BR0112633A (pt) Método para substituir, translocar e empilhar dna em genomas eucarióticos
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
DE69636288D1 (de) Samenstrenung resistenz
BR9814404A (pt) &#34; clonagem de expressão em fungos filamentosos &#34;
BRPI0411182A (pt) método para aumentar a toleráncia de uma planta ao estresse abiótico, método para aumentar a biomassa de uma planta, construto de ácido nucléico, polipeptìdio isolado e célula de planta
SG147468A1 (en) High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
PT1428878E (pt) Processo para a produção e purificação de eritropoietina
BR9809433A (pt) Moléculas de dna enzimáticas
PE20040900A1 (es) Acidos nucleicos inmunoestimuladores
AR044724A1 (es) Promotores del virus de la rizadura amarilla del cestrum
AR005568A1 (es) Moleculas y construcciones de adn para aumentar la expresion de genes foraneos; celulas y plantas transformadas y metodo para producirlas
ATE319854T1 (de) Enzymaktive dna moleküle
BRPI9811031B8 (pt) processo para preparar uma célula produtora de epo humana, processo para preparar epo humana, construção de dna para ativação de gene de epo endógeno, bem como plasmìdio.
WO2005005643A3 (en) Chloroplast transformation of duckweed
PL1608752T3 (pl) Sposób izolacji kwasów nukleinowych
AR043862A1 (es) Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina
BR9811853A (pt) Processos para aumentar o rendimento em plantas
AR014528A1 (es) Adn que comprende una secuencia de nucleotidos que se puede traducir a una proteina con actividad de invertasa, proteina derivada del adn que tieneactividad de invertasa pero que carece de actividad beta-fructofuranosidasa; metodo para producir adn y dicho metodo donde el adn es producido por una
EP1331264A4 (en) PROCESS FOR CULTURING HUMAN CHONDROCYTES
WO2003089617A3 (en) Methods for increasing homologous recombination of a nucleic acid sequence
BR0316822A (pt) Recombinação de dna especìfica da sequência em células eucarióticas
ES2161736T3 (es) Oligonucleotidos para la deteccion de enterobacteriaceas.
BR9903603A (pt) Processo para produzir um produto fermentativo utilizando um microorganismo, e, microorganismo

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/02/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 09.02.2020